Compounds > temozolomide
Page last updated: 2024-08-16

temozolomide and interleukin-8

temozolomide has been researched along with interleukin-8 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Ahn, NG; Dallaglio, K; Ellis, LZ; Fujita, M; Gonzalez, R; Lewis, KD; Liu, W; Luo, Y; McCarter, MD; Norris, DA; Robinson, SE; Robinson, WA; Roop, DR; Spritz, RA; Takeda, M1
Armenia, E; Barbarisi, A; Barbarisi, M; De Sena, G; Iaffaioli, RV; Quagliariello, V; Schiavo, L; Tafuto, S1
Armenia, E; Aurilio, C; Barbarisi, A; Barbarisi, M; Botti, G; De Sena, G; Iaffaioli, RV; Libutti, M; Maurea, N; Quagliariello, V1
Ahmed, AU; Atashi, F; Baisiwala, S; Caragher, SP; Dey, M; Guo, D; Hasan, T; Horbinski, CM; James, CD; Lee, G; Lesniak, MS; Park, CH; Shireman, JM; Wang, JY; Wu, M1
Acker, G; Brandenburg, S; Jelgersma, C; Koch, A; Kremenetskaia, I; Mueller, S; Nieminen-Kelhä, M; Rubarth, K; Urbantat, RM; Vajkoczy, P; Zollfrank, J1
Lathoria, K; Patrick, S; Sen, E; Suri, V1

Other Studies

6 other study(ies) available for temozolomide and interleukin-8

ArticleYear
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.
    The Journal of investigative dermatology, 2012, Volume: 132, Issue:10

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Coloring Agents; Dacarbazine; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Interleukin-8; Melanoma; Mice; Mice, Nude; Paclitaxel; Side-Population Cells; Skin Neoplasms; Temozolomide; Up-Regulation; Xenograft Model Antitumor Assays

2012
Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme.
    Journal of cellular physiology, 2018, Volume: 233, Issue:10

    Topics: Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hydrogel, Polyethylene Glycol Dimethacrylate; Interleukin-6; Interleukin-8; Molecular Targeted Therapy; Nanoparticles; Polymers; Quercetin; Temozolomide; Vascular Endothelial Growth Factor A

2018
Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells.
    Phytotherapy research : PTR, 2019, Volume: 33, Issue:6

    Topics: Afatinib; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Boswellia; Cardiotonic Agents; Cell Line, Tumor; Chemokine CXCL12; ErbB Receptors; Glioblastoma; Humans; Interleukin-6; Interleukin-8; Leukotriene B4; Lipid Peroxidation; Myocytes, Cardiac; Reactive Oxygen Species; Temozolomide; Transcription Factor RelA; Triterpenes

2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.
    Cell death & disease, 2019, 03-29, Volume: 10, Issue:4

    Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Plasticity; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Glioblastoma; Histones; Humans; Interleukin-8; Kruppel-Like Factor 4; Mice; Mice, Nude; Neoplasm Recurrence, Local; Receptors, Interleukin-8B; Temozolomide; Xenograft Model Antitumor Assays

2019
Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy.
    International journal of molecular sciences, 2021, Oct-16, Volume: 22, Issue:20

    Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Models, Animal; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Interleukin-8; Male; Mice; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Phenylurea Compounds; Prognosis; Receptors, Interleukin-8B; Signal Transduction; Survival Analysis; Temozolomide; Tumor Microenvironment; Tumor-Associated Macrophages; Young Adult

2021
Reduced YAP1 and FOLR1 in gliomas predict better response to chemotherapeutics.
    Cellular signalling, 2023, Volume: 109

    Topics: Brain Neoplasms; Folate Receptor 1; Glioma; Humans; Interleukin-6; Interleukin-8; Mutation; Temozolomide; Transcription Factors

2023